.Speaker Group: DTCT US 2024- Speakers

Dana Immerso

As the Director of Strategic Partnerships for Avrok Biosciences, Dana Immerso combines her expertise in patient recruitment and engagement with her role in forging collaborative alliances. Her leadership within Avrok Biosciences underscores her commitment to driving innovation in discovery research and clinical trials while prioritizing patient-centricity. Drawing from her background as a rare disease patient… Read more »

Stephen Framil

As the Corporate Global Head of Accessibility at Merck & Co., Inc., Dr. Stephen Framil brings over 25 years of executive leadership in business strategy and innovation, policy and governance, procedure and operations, and portfolio management expertise – leading global cross organizational enterprise, consultant, and start-up teams in the Health & Life Sciences, Finance Services,… Read more »

Alexander Miles Welbourn

Miles Welbourn is a biomedical engineer by training, and he is an expert in biomechanics and wearable biosensors. He works as the technical lead for the Pfizer Innovation Research Lab in Cambridge, MA as part of a multidisciplinary team often comprised of clinicians, research scientists, data scientists, and engineers to develop and validate precise and… Read more »

Hao Zhang

Dr. Hao Zhang is currently the Director, Digital Healthcare Innovation at Mitsubishi Tanabe Pharma America, Inc. Previously he was an Associate Director/Senior Manager in Pfizer Inc, in the Digital Medicine group. He has been working on evaluating, developing, validating and implementing new digital health technologies and digital endpoints in clinical trials and for clinical care. Prior to his digital medicine… Read more »